The highlights from continuing operations for the fourth quarter and year ended December 31, 2008 are as follows:

Net sales were $732.3 million for the fourth quarter of 2008, down 6.6% compared to $784.1 million for the same period in the prior year. Net sales were $3,380.1 million for the year ended December 31, 2008, up 10.3% compared to $3,065.2 million for the same period in the prior year.

Adjusted EBITDA from continuing operations was $131.4 million for the fourth quarter of 2008, down 14.2% compared to $153.1 million for the same period in the prior year. Adjusted EBITDA from continuing operations was $638.9 million for the year ended December 31, 2008, up 6.1% compared to $602.4 million in 2007.

On a constant-currency basis, net sales were up 0.6% and Adjusted EBITDA from continuing operations was down 8.0% for the fourth quarter of 2008, and were up 6.3% and 1.1%, respectively, for the year ended December 31, 2008.

Net loss from continuing operations for the fourth quarter of 2008 was $(734.1) million, including after-tax net non-recurring and other special charges of $748.4 primarily related to goodwill impairment charges recorded within several businesses. Net income from continuing operations for the fourth quarter of 2007 was $14.7 million, including after-tax net non-recurring and other special charges of $15.5 million.

Net loss from continuing operations for the year ended December 31, 2008 was $(634.6) million, including after-tax net non-recurring and other special charges of $778.5 million primarily related to the goodwill impairment charges recorded in the fourth quarter of 2008. Net income from continuing operations for the year ended December 31, 2007 was $81.5 million, including after-tax net non-recurring and other special charges of $36.1 million.

Diluted loss per share from continuing operations for the fourth quarter of 2008 was $(9.91), including after-tax net non-recurring and other special charges of $10.10. Excluding net non-recurring and other special charges, diluted earnings per share from continuing operations were $0.19 in the fourth quarter of 2008. Diluted earnings per share from continuing operations for the fourth quarter of 2007 were $0.19, including after-tax net non-recurring and other special charges of $0.20. Excluding net non-recurring and other special charges, diluted earnings per share from continuing operations were $0.39 in the fourth quarter of 2007.

Diluted loss per share from continuing operations for the full year 2008 was $(8.58), including after-tax net non-recurring and other special charges of $10.47. Excluding net non-recurring and other special charges, diluted earnings per share from continuing operations were $1.89 for the full year 2008. Diluted earnings per share from continuing operations for the full year 2007 were $1.07, including after-tax net non-recurring and other special charges of $0.47. Excluding net non-recurring and other special charges, diluted earnings per share from continuing operations were $1.54 in the full year 2007.

As previously announced, we completed the sale of our Pool and Spa Chemicals business in October 2008 and recorded a gain on sale, net of taxes of $40.5 million. The results of this business have been accounted for as a discontinued operation in the consolidated financial statements for all periods presented.

Commenting on Rockwood’s performance, Seifi Ghasemi, chairman and chief executive officer, said, “The significant slowdown in global business activity affected our revenues but our proactive cost control measures enabled us to achieve Adjusted EBITDA margins at the 18% level during the fourth quarter despite the poor economic climate. We have been focused on consolidating facilities, reducing work hours and headcount, controlling discretionary expenses, and maintaining our pricing. Recognizing that we are in a global recession, we will remain intensely focused on the items we can control. With cash and cash equivalents at year end of about $469 million, we will also continue to focus on maintaining our strong liquidity position. We are confident that this proactive stance, combined with the strength of our portfolio, our major market positions and the diversity of our customer base, will enable us to perform up to our high expectations.”

Fourth quarter results, as compared with the same period a year ago, are summarized below:

Specialty Chemicals:

Net sales decreased 5.9% in part due to the impact of currency changes, while Adjusted EBITDA was up 3.2% primarily from higher selling prices, partially offset by lower volumes and higher raw material costs.

In our Fine Chemicals business, higher selling prices of lithium products were partially offset by lower volumes of lithium products and metal sulfide applications.

In our Surface Treatment business, lower volumes, particularly in automotive applications, were partially offset by increased selling prices, the impact from bolt-on acquisitions and cost control measures.

In both the businesses, higher raw material costs and the impact of currency changes had a negative impact on results.

Performance Additives:

Net sales and Adjusted EBITDA decreased 23.5% and 75.6%, respectively.

Results were negatively impacted by lower volumes of construction-related products.

Higher raw material costs, primarily in our Color Pigments and Services business, also had a negative impact on Adjusted EBITDA, partially offset by increased selling prices and the impact of a bolt-on acquisition.

Titanium Dioxide Pigments:

Net sales and Adjusted EBITDA increased 42.3% and 5.0%, respectively. However, net sales and Adjusted EBITDA declined significantly excluding the impact of the venture with Kemira that was completed in September 2008.

Market conditions, including current industry overcapacity particularly serving the construction industry, have continued to negatively impact this segment.

Lower volumes for functional additives and titanium dioxide products, primarily commodity grade, as well as higher energy and raw material costs, had a negative effect on results.

Advanced Ceramics:

Net sales and Adjusted EBITDA decreased 13.5% and 20.1%, respectively.

Lower volumes in most applications were partially offset by increased volumes of medical products.

Higher raw material and energy costs also had a negative impact on Adjusted EBITDA.

Specialty Compounds:

Net sales and Adjusted EBITDA decreased 23.6% and 18.0%, respectively.

Results were down primarily from lower volumes in wire and cable applications, partially offset by increased selling prices.

Higher raw material costs also had a negative impact on Adjusted EBITDA.

Corporate and Other:

Corporate costs were down due to lower compensation-related costs and lower professional fees recorded in the fourth quarter of 2008, as well as other cost control measures.

Other Items:

Impairment charges: As a result of the significant drop in global stock valuations, the substantial reduction in the market valuation of Rockwood and comparable companies, and the continuing negative global economic and market outlook, we recorded a non-cash charge of $809.5 million in the fourth quarter of 2008 to write-down the carrying value of goodwill within several businesses. The write-down had no impact on the company’s debt, Adjusted EBITDA or calculation of lender covenants.

Restructuring and other severance costs of $29.6 million were recorded in the fourth quarter of 2008 primarily related to miscellaneous headcount reductions throughout the company.